Biotech · Private company
NextPoint Therapeutics, Inc.
Track this companyFree. Adds NextPoint Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NPX267Phase 1 · Metastatic Malignant NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- NPX372Phase 1 · Metastatic Malignant NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- NPX887Phase 1 · Metastatic Malignant NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor MalignanciesPHASE1 · RECRUITING · started May 1, 2026ClinicalTrials.gov NCT07563829 · fetched Nov 12, 2026
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2PHASE1 · RECRUITING · started Jan 22, 2024ClinicalTrials.gov NCT06240728 · fetched Nov 12, 2026
- A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7PHASE1 · SUSPENDED · started Jul 21, 2023ClinicalTrials.gov NCT05958199 · fetched Nov 12, 2026